Señales en vivo de BPCR.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:26):

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products...

Stats
Volumen de hoy	2.08M
Volumen promedio	1.78M
Capitalización de mercado	10.77M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $0 ) 2024-06-12
Last Dividend	$0.0175 ( 2023-08-17 )
Next Dividend	$0 ( N/A )
P/E	11.00
ATR14	$0.00200 (0.23%)

Volumen Correlación

Largo: -0.08 (neutral)

Corto: -0.91 (very strong negative)

Signal:(50.233) Neutral

BioPharma Credit PLC Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioPharma Credit PLC Correlación - Moneda/Commodity

0.00
( neutral )

0.13
( neutral )

0.00
( neutral )

0.27
( neutral )

BioPharma Credit PLC Finanzas

Annual	2023
Ingresos:	$110.49M
Beneficio Bruto:	$110.49M (100.00 %)
EPS:	$0.0828

FY	2023
Ingresos:	$110.49M
Beneficio Bruto:	$110.49M (100.00 %)
EPS:	$0.0828

FY	2022
Ingresos:	$184.25M
Beneficio Bruto:	$184.25M (100.00 %)
EPS:	$0.130

FY	2021
Ingresos:	$87.97M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$0.0620

Financial Reports:

No articles found.

BioPharma Credit PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0175 (N/A)	$0.0450 (N/A)	$0.0158 (N/A)	$0.0175 (N/A)	$0.0175 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BioPharma Credit PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.79 - good (77.86%) | Divividend Growth Potential Score: 4.24 - Stable (15.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0100	2017-09-28
Last Dividend	$0.0175	2023-08-17
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	$0.385	--
Avg. Dividend % Per Year	1.46%	--
Score	4.14	--
Div. Sustainability Score	7.79
Div.Growth Potential Score	4.24
Div. Directional Score	6.01	--

Next Divdend (Est)
(2024-07-01)

$0.0175 Estimate 21.90 %

Dividend Stability

0.58 Average

Dividend Score

4.14

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.0200	0.02%
2018	$0.0594	0.06%
2019	$0.0543	0.05%
2020	$0.0479	0.05%
2021	$0.0554	0.06%
2022	$0.0975	0.10%
2023	$0.0508	5.35%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PNS.L	Dividend King	2023-06-29	Semi-Annually	31	3.82%
FSTA.L	Dividend Knight	2023-06-22	Annually	33	0.95%
AFM.L	Dividend Knight	2023-09-07	Annually	8	1.57%
THS.L	Dividend Knight	2023-06-08	Annually	7	3.10%
LOK.L	Dividend King	2023-05-04	Semi-Annually	18	34.89%
CML.L	Dividend King	2023-08-03	Semi-Annually	32	2.93%
RKT.L	Dividend Knight	2023-08-03	Semi-Annually	23	1.95%
HEFT.L	Dividend Knight	2023-06-01	Semi-Annually	53	1.20%
ATS.L	Dividend Knight	2023-08-24	Semi-Annually	26	0.94%
UPR.L	Dividend Junior	2023-09-28	Annually	5	0.34%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.799	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0799	1.200	7.34	8.80	[0 - 0.3]
returnOnEquityTTM	0.0813	1.500	-0.208	-0.312	[0.1 - 1]
payoutRatioTTM	0.828	-1.000	1.722	-1.722	[0 - 1]
currentRatioTTM	9.79	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	9.78	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.51	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0946	2.00	9.95	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.799	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.100	0.800	-2.67	-2.13	[0.5 - 2]
Total Score				7.79

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.57	1.000	9.03	0	[1 - 100]
returnOnEquityTTM	0.0813	2.50	-0.134	-0.312	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	11.60	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0946	2.00	9.97	10.00	[0 - 30]
payoutRatioTTM	0.828	1.500	1.722	-1.722	[0 - 1]
pegRatioTTM	-0.390	1.500	-5.94	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.908	1.000	10.00	0	[0.1 - 0.5]
Total Score				4.24

BioPharma Credit PLC